The Future of IP in the Regulation of NGTs

The European Union has reached a provisional agreement on the regulation of New Genomic Techniques (NGTs) in plant breeding, marking a significant milestone in balancing innovation, fair access, and competitiveness within the sector. This development has been met with relief by stakeholders, as the long-awaited regulation aims to clarify the regulatory landscape for NGTs, particularly for Category 1 plants.

Under the new framework, Category 1 NGT plants will be classified as equivalent to conventional breeding techniques and will not be subject to the stringent regulations typically applied to Genetically Modified Organisms (GMOs). This classification is intended to facilitate the development and commercialization of NGTs, which have the potential to revolutionize plant breeding by enabling precise genetic modifications.

However, the agreement also addresses concerns related to intellectual property (IP) rights, a critical aspect of the NGT debate. To register an NGT1 plant, breeders or companies will be required to disclose all existing or pending patents related to the technique used. This information will be made publicly available in a database, enhancing transparency and ensuring that competitors have access to relevant IP information. While this requirement is designed to promote fairness and prevent monopolistic practices, experts have expressed concerns about the complexity of navigating these obligations, particularly regarding pending patents.

Additionally, the regulation encourages voluntary disclosure of a patent holder's intention to license the use of a patented NGT1 plant or product under equitable conditions. This measure aims to strike a balance between protecting intellectual property and ensuring that farmers and breeders have access to innovative plant varieties.

Jocelyn Bosse, a lecturer in Intellectual Property Law at Queen's University in Belfast, highlights the ongoing focus on patents in the NGT debate. Although the European Parliament's proposal to ban patents for NGTs was rejected, patents remain a contentious issue. To address this, a patenting expert group will be established, comprising members from all Member States, the European Patent Office, and the Community Plant Variety Office. This group will review the effects of patents on NGT plants, providing insights into their impact on innovation, seed availability, and the competitiveness of the EU plant breeding sector.

Furthermore, the Commission has committed to publishing a study within one year of the regulation's entry into force, evaluating the impact of patenting on innovation, seed availability for farmers, and the competitiveness of the EU plant breeding sector. This comprehensive approach underscores the EU's commitment to fostering a dynamic and sustainable plant breeding industry, while safeguarding the interests of farmers, breeders, and IP holders.

In conclusion, the provisional agreement on NGT regulation represents a significant step towards harmonizing the regulatory framework for plant breeding in the EU. By classifying Category 1 NGT plants as equivalent to conventional breeding and addressing IP concerns through increased transparency and disclosure requirements, the regulation aims to promote innovation while ensuring fair access to new technologies. The establishment of the patenting expert group and the planned study further demonstrate the EU's dedication to balancing the competing interests at stake, ultimately benefiting the entire European plant breeding sector.